Skip to main content
Clinical Trials/KCT0008833
KCT0008833
Not yet recruiting
未知

Effect of atelocollagen injection in patients with calcific tendinitis

The Catholic University of Korea, Eunpyeong St. Mary's Hospital0 sites42 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the musculoskeletal system and connective tissue
Sponsor
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Enrollment
42
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Eligibility Criteria

Inclusion Criteria

  • Selection Criteria
  • ? Adults aged 20 years or older and under 70 years old.
  • ? Patients in whom calcification of 5mm or more is observed on plain radiographs.
  • ? Patients who, if taking concomitant medications continuously during the clinical trial period, have verified prescriptions within the last week and agree to maintain a consistent dose throughout the study period.
  • ? Individuals who have agreed to participate in this study and have provided written consent.

Exclusion Criteria

  • Exclusion Criteria
  • ? Patients with a history of infectious arthritis, rheumatoid arthritis, tumors, or fractures.
  • ? Patients with hypersensitivity.
  • ? Patients with a history of anaphylactic reactions.
  • ? Patients with ongoing autoimmune diseases or a past history of them, either in the patient or their family.
  • ? Patients allergic to grafts.
  • ? Patients allergic to porcine (pig) proteins.
  • ? Patients deemed inappropriate for the trial due to mental illnesses or at the discretion of the trial administrator.
  • ? Patients who have received intra\-articular steroid or other injection treatments within a month prior to the decision for the procedure.
  • ? Patients who include oral steroids among their concomitant medications.

Outcomes

Primary Outcomes

Not specified

Similar Trials